Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

NCT04911790 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

131650

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Experimental Group

Sponsor

Sinovac Research and Development Co., Ltd.